The session highlighted how these medications, when combined with Crossovers integrated care model, can improve outcomes, lower long-term costs, and enhance employee well-being The Rising Cost of Chronic Conditions: Why It Matters to Employers Nearly three-quarters of U.S
10.1016/j.phymed.2024.156203 167 YangS.YinW.DingY.LiuF
They were developed to treat type 2 diabetes, but the dramatic weight loss seen as a "side benefit" is what turned them into household names
Med (United States)
Exp Gerontol 23(1):116122 Frasca D, Romero M, Diaz A, Alter-Wolf S, Ratliff M, Landin AM, Riley RL, Blomberg BB (2012) A molecular mechanism for TNF--mediated downregulation of B cell responses
, Parker, V